Dedifferentiated Chondrosarcoma from Molecular Pathology to Current Treatment and Clinical Trials
W Zając, J Dróżdż, W Kisielewska, W Karwowska… - Cancers, 2023 - mdpi.com
Simple Summary Dedifferentiated chondrosarcoma is a rare type of cancer that is very
aggressive and has a poor prognosis with poor survival rates. This disease can affect …
aggressive and has a poor prognosis with poor survival rates. This disease can affect …
A promising role of noble metal NPs@ MOFs in chondrosarcoma management
Z Huang, K Tian, Y Xue, F Luo - Nanoscale, 2025 - pubs.rsc.org
Chondrosarcoma, a challenging and malignant neoplasm originating from cartilage cells,
poses significant diagnostic and therapeutic hurdles due to its resistance to conventional …
poses significant diagnostic and therapeutic hurdles due to its resistance to conventional …
Chondrosarcoma of the femur: is local recurrence influenced by the presence of an extraosseous component?
Simple Summary This study focused on conventional central chondrosarcoma (CS) in the
femur, investigating the impact of an extraosseous tumor component on local recurrence …
femur, investigating the impact of an extraosseous tumor component on local recurrence …
The stimulation of exosome generation by visfatin polarizes M2 macrophages and enhances the motility of chondrosarcoma
Chondrosarcoma is a malignant bone tumor that arises from abnormalities in cartilaginous
tissue and is associated with lung metastases. Extracellular vesicles called exosomes are …
tissue and is associated with lung metastases. Extracellular vesicles called exosomes are …
Emerging Treatments Targeting the Tumor Microenvironment for Advanced Chondrosarcoma
Chondrosarcoma (ChS), a malignant cartilage-producing tumor, is the second most
frequently diagnosed osseous sarcoma after osteosarcoma. It represents a very …
frequently diagnosed osseous sarcoma after osteosarcoma. It represents a very …
Update of cartilaginous tumours according to the WHO classification 2020
S Gomez-Pena, ÁR de Eusebio, JA García… - Radiología (English …, 2024 - Elsevier
Cartilaginous tumours are a large and heterogeneous group of neoplasms characterised by
the presence of a chondroid matrix, with lobular growth and arcuate, ring-like or popcorn-like …
the presence of a chondroid matrix, with lobular growth and arcuate, ring-like or popcorn-like …
Visfatin Facilitates VEGF-D-Induced Lymphangiogenesis through Activating HIF-1α and Suppressing miR-2277-3p in Human Chondrosarcoma
Chondrosarcoma is a malignant bone tumor that arises from abnormalities in cartilaginous
tissue and is associated with lung metastases. Lymphangiogenesis plays an essential role …
tissue and is associated with lung metastases. Lymphangiogenesis plays an essential role …
Mesenchymal Chondrosarcoma from Diagnosis to Clinical Trials
M Dudzisz-Śledź, M Kondracka, M Rudzińska… - Cancers, 2023 - mdpi.com
Simple Summary Mesenchymal chondrosarcoma (MCS) is a subtype of chondrosarcoma
with rare occurrence and poor survival rates. MCS stains positive for S-100 and SOX9 as …
with rare occurrence and poor survival rates. MCS stains positive for S-100 and SOX9 as …
Development and validation of a nomogram for predicting prognosis of high-grade chondrosarcoma: A surveillance, epidemiology, and end results-based population …
Y Sun, C Ouyang, Y Zhang, Y Li, Y Liu… - Journal of …, 2023 - journals.sagepub.com
Background The incidence of chondrosarcoma is increasing every year, and the treatment
and prognosis of patients with high-grade chondrosarcoma are becoming more and more …
and prognosis of patients with high-grade chondrosarcoma are becoming more and more …
Transcriptomic data integration and analysis revealing potential mechanisms of doxorubicin resistance in chondrosarcoma cells
JC Chen, MS Chen, SK Jiang, CY Eaw, YJ Han… - Biochemical …, 2025 - Elsevier
Chondrosarcoma is a type of bone cancer that originates from cartilage cells. In clinical
practice, surgical resection is the primary treatment for chondrosarcoma, but chemotherapy …
practice, surgical resection is the primary treatment for chondrosarcoma, but chemotherapy …